Stock Rises Amid Clinical Trial Progress: What's Going On?

benzinga.com/news/25/05/45528474/altimmune-alt-stock-rises-amid-clinical-trial-progress-whats-going-on

Shares of Altimmune Inc (NASDAQ:ALT) rose 5.8% to $5.82 on Tuesday afternoon, despite no new company-specific news for the session. The biotech stock is trending on the social media platform Stocktwits, possibly fueled by high short interest and investor excitement over recent clinical…

This story appeared on benzinga.com, 2025-05-20 19:24:20.
The Entire Business World on a Single Page. Free to Use →